🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Intensity Therapeutics, Inc. (INTS)
NASDAQ: INTS · Real-Time Price · USD
2.500
-0.140 (-5.30%)
At close: Nov 19, 2026, 4:00 PM EST
2.510
+0.010 (0.40%)
After-hours: Nov 19, 2026, 4:10 PM EST

Intensity Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
8.4911.922.598.561.314.54
Short-Term Investments
---6.22--
Cash & Short-Term Investments
8.4911.922.5914.781.314.54
Cash Growth
20.19%360.27%-82.47%1026.22%-71.10%-51.28%
Other Receivables
-----0.05
Receivables
-----0.05
Prepaid Expenses
1.010.790.770.690.060.07
Other Current Assets
----0.080.07
Total Current Assets
9.512.713.3615.461.454.73
Property, Plant & Equipment
0.080.10.120.150.140.32
Other Long-Term Assets
0.711.31.31.680.170.17
Total Assets
10.2914.14.7817.31.765.22

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
1.650.581.223.050.60.17
Accrued Expenses
0.91.530.510.890.330.34
Short-Term Debt
----4.352.02
Current Portion of Leases
0.030.030.030.020.140.18
Other Current Liabilities
----1.391.01
Total Current Liabilities
2.582.151.763.966.823.72
Long-Term Leases
0.050.080.110.14-0.14
Other Long-Term Liabilities
---0.040.040.04
Total Liabilities
2.642.231.874.136.863.9

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
---0-0
Additional Paid-In Capital
95.0390.2769.763.6823.5622.39
Retained Earnings
-87.37-78.39-66.78-50.52-38.65-31.07
Total Common Equity
7.6511.882.9213.16-15.1-8.68
Shareholders' Equity
7.6511.882.9213.16-5.11.32
Total Liabilities & Equity
10.2914.14.7817.31.765.22

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
0.090.110.140.164.492.34
Net Cash (Debt)
8.4111.812.4514.62-3.182.2
Net Cash Growth
20.98%381.69%-83.23%---75.09%
Net Cash Per Share
3.108.714.4142.41-23.3116.10
Filing Date Shares Outstanding
3.32.540.610.550.140.14
Total Common Shares Outstanding
3.32.520.60.550.140.14
Working Capital
6.9210.561.6111.51-5.371.01
Book Value Per Share
2.324.704.8224.00-110.69-63.67
Tangible Book Value
7.6511.882.9213.16-15.1-8.68
Tangible Book Value Per Share
2.324.704.8224.00-110.69-63.67
SEC Filings: 10-K · 10-Q